Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.06 +0.72%
EPS Growth %: -266.7%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -266.7%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $38.6 million versus the consensus estimate of $37.71 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2022 revenue of $185-195 million, versus the consensus of $189.4 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- AutoZone beats profit view but misses on revenue
- Talos Energy closes $420M Gulf of America deepwater asset deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
